News Release Highlights:
Battery X Metals Inc.'s wholly-owned subsidiary, Battery X Rebalancing Technologies Inc., has entered into a Commercial Revenue Share Agreement with an arm's length, independent Vancouver-based automotive service center specializing in out-of-warranty Tesla vehicles. The agreement marks the first commercial deployment of its patent-pending, second-generation lithium-ion battery rebalancing machine ("Prototype 2.0") in a live customer-facing environment.
Under the terms of the Agreement, Battery X Rebalancing Technologies will receive 20% of gross service revenue per rebalancing procedure, plus applicable taxes, with no direct costs incurred for labor, overhead, or shop operations-establishing a potential early-stage revenue stream with no direct operating expenses.
The Revenue Share Agreement follows a successful real-world performance trial in which Prototype 2.0 restored a severely imbalanced light-duty electric truck's estimated driving range from approximately 40 kilometers to 295 kilometers-a 255-kilometer increase representing a 637.5% improvement-validating the commercial potential of the platform.
RLTR becomes top-performing AI stock of the week, surpassing tech heavyweights Microsoft (MSFT), NVIDIA (NVDA), Alphabet (GOOGL), Amazon (AMZN), Meta (META), AMD, and Palantir (PLTR),
Read More
Harnessing subaudible frequencies and subliminal affirmations, this audio system supports mindset transformation through proven neuroplasticity principles in just minutes a day.
Read More
With ingredient transparency, stack-friendly simplicity, and daily-use reliability, GenuinePurity is quickly becoming the go-to NMN supplement for performance-minded consumers and longevity-focused lifestyles.
Read More
Explore how Jeff Clark's "Bill Payer" method uses a simple, three-stock options strategy to help individuals pursue monthly income-starting with just 15 minutes a day and a basic brokerage account.
Read More
Patent-pending floating forms architecture now available to license - for software companies ready to scale, stand out, and redefine the future of SaaS.
Read MoreDelivery of U.S.-Manufactured Ballistic Protection Products Expected in Q3; AI Demonstration Supports U.S. DoD Operational Objectives in the Pacific Rim
Read MoreNew data shows Telomir-1 fully reverses STAT1 gene silencing by DNA methylation - a key immune regulator suppressed in cancer - delivering stronger epigenetic effects than Paclitaxel or Rapamycin in aggressive PC3 tumor models.
Read More
With its latest acquisition, C2 Blockchain Inc. (OTC:CBLO) strengthens its position as the leading public market holder of DOG Coin - the Bitcoin-native meme asset.
Read More
Inside America's Rediscovered Rare Earth Deposits - and Why Neodymium, Gallium, and Lithium May Fuel the Next Wave of AI Innovation, Industrial Policy, and Strategic Reshoring
Read More